1. Home
  2. SLGL

SLGL

Sol-Gel Technologies Ltd.

Logo Sol-Gel Technologies Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Founded: 1997 Country:
Israel
Israel
Employees: 36 City: N/A
Market Cap: 26.2M IPO Year: 2018
Target Price: $8.00 AVG Volume (30 days): 32.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.01 EPS Growth: N/A
52 Week Low/High: $0.79 - $4.20 Next Earning Date: 05-10-2024
Revenue: $1,554,000 Revenue Growth: -59.98%
Revenue Growth (this year): 57.53% Revenue Growth (next year): 154.17%

Share on Social Networks: